Clinical trial
Double-blind, Placebo-controlled Crossover Evaluation of the Effect of PUR003 on Subjects With Asthma
NCT00989521 is registered in ClinicalTrials.gov with Pulmatrix Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind, Placebo-controlled Crossover Evaluation of the Effect of PUR003 on Subjects With Asthma
- Lead sponsor
- Pulmatrix Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- October 31, 2011
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.